Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Express Scripts
Colorcon
Dow
Moodys
Harvard Business School
Mallinckrodt

Last Updated: October 18, 2019

DrugPatentWatch Database Preview

Claims for Patent: 8,466,175

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,466,175
Title:Form of S-omeprazole
Abstract: The present invention relates to a novel form of the (-)-enantiomer of 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1H-be- nzimidazole, i.e. S-omeprazole. More specifically, it relates to a novel form of the magnesium salt of the S-enantiomer of omeprazole trihydrate. The present invention also relates to processes for preparing such a form of the magnesium salt of S-omeprazole and pharmaceutical compositions containing it. Furthermore, the present invention also relates to new intermediates used in the process.
Inventor(s): Cotton; Hanna (Sodertalje, SE), Kronstrom; Anders (Sodertalje, SE), Mattson; Anders (Sodertalje, SE), Moller; Eva (Sodertalje, SE)
Assignee: AstraZeneca AB (Sodertalje, SE)
Application Number:13/298,373
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,466,175
Patent Claims: 1. A method of treating Helicobacter infections comprising the administration of an effective amount of the magnesium salt of S-omeprazole trihydrate and an antibacterial compound to a patient in need thereof.

2. The method according to claim 1, wherein the magnesium salt of S-omeprazole trihydrate is represented by FIG. 1.

3. The method according to claim 1, wherein the magnesium salt of S-omeprazole trihydrate is characterized by the following peaks in its X-ray diffractogram: TABLE-US-00007 d-value/.ANG. Relative Intensity 2.67 m 2.79 m 3.27 m 3.52 s 3.82 s 3.96 vs 4.14 m 5.2 m 5.6 m 6.7 vs 6.9 s 8.3 w 16.6 vs.

4. The method according to claim 1, wherein the magnesium salt of S-omeprazole trihydrate is in a highly crystalline form.

5. The method according to claim 1, wherein the magnesium salt of S-omeprazole trihydrate is in a stable form.

6. The method according to claim 1, wherein the magnesium salt of S-omeprazole trihydrate is suitable for oral administration.

7. The method according to claim 6, wherein the antibacterial compound is suitable for oral administration.

8. The method according to claim 6, wherein the antibacterial compound is suitable for parenteral administration.

9. The method according to claim 1, wherein the magnesium salt of S-omeprazole trihydrate is suitable for parenteral administration.

10. The method according to claim 9 wherein the antibacterial compound is suitable for oral administration.

11. The method according to claim 9, wherein the antibacterial compound is suitable for parenteral administration.

12. The method according to claim 1, wherein the antibacterial compound is suitable for oral administration.

13. The method according to claim 1, wherein the antibacterial compound is suitable for parenteral administration.

14. The method according to claim 1, wherein the total daily dose of the magnesium salt of S-omeprazole trihydrate is from 10 mg to 80 mg.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Boehringer Ingelheim
Merck
Moodys
McKesson
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.